These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7415155

  • 1. [Treatment of diabetics with metformin].
    Tikholov K, Kalpazanova N, Peshev P, Kostov M, Kusinikov V.
    Vutr Boles; 1980; 19(4):21-4. PubMed ID: 7415155
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Leo-insulins in the treatment of diabetes. Experiences from an internal medicine practice].
    Roth U.
    Fortschr Med; 1980 Jul 03; 98(25):995-8. PubMed ID: 7005038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
    D'Argenzio R, Cavallo P, Merante D, Morelli A.
    Minerva Endocrinol; 1996 Sep 03; 21(3):101-10. PubMed ID: 9072666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I, Almazov VA, Shlyakhto E.
    Diabetes Obes Metab; 2006 Jul 03; 8(4):456-65. PubMed ID: 16776753
    [Abstract] [Full Text] [Related]

  • 14. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M, Nilsson A, Janzon L, Groop L.
    Diabet Med; 1997 Feb 03; 14(2):123-31. PubMed ID: 9047089
    [Abstract] [Full Text] [Related]

  • 15. Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
    Fanghänel G, Silva U, Sanchez-Reyes L, Sisson D, Sotres D, Torres EM.
    Rev Invest Clin; 1998 Feb 03; 50(5):389-94. PubMed ID: 9949668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M, Lam S.
    Cardiol Rev; 2007 Feb 03; 15(5):264-71. PubMed ID: 17700385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Value of delayed-action metformin in the treatment of diabetes].
    Pousset G, Robert M, Guinet P.
    Lyon Med; 1971 Sep 26; 226(14):219-21. PubMed ID: 5117728
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.